Neonatal seizure: how sure about diagnosis and treatment? A mini review of previous knowledge
Iranian Journal of Child Neurology,
Vol. 14 No. 4 (2020),
1 October 2020
,
Page 9-16
https://doi.org/10.22037/ijcn.v14i4.32187
Abstract
Seizure is the most common neurologic event in the neonatal period when the immature, growing brain is vulnerable to various injuries. Seizure might be present as an atypical feature in neonates, which makes diagnosis a challenge. A vast majority of seizures are symptomatic due to an underlying cause, searching for etiology to remove them leads to more effective therapy. However, there is doubt about the diagnosis of seizures and the best treatment for them. Here, we reviewed articles related to diagnosis and treatment of neonatal seizures to evaluate the available evidence. The results showed that despite numerous studies on the topic, neither an implicit diagnosing method nor a therapeutic regime was proposed. It was also observed that phenobarbital prescription was reduced while newer anti-seizure medication such as levetiracetam was further prescribed. Seizure, the most common neurologic disorder in neonates, is a challenging topic for both neonatologists and neurologists. Since patients are critically ill, designing a randomized clinical trial appears not to be easy for neonates admitted to a neonatal intensive care unit. Moreover, both the diagnosis and treatment of seizures should be reevaluated based on neonatal characteristics. In the recent decade, new less harmful anti-seizure medications are being replaced with old ones.
- Neonatal seizure; Amplitude integrated electro encephalogram; Anti-seizure medication
How to Cite
References
Ahmad KA, Desai SJ , Bennett MM, Ahmad SF, Clark RH, Tolia VN . Changing antiepileptic
drug use for seizures in US neonatal intensive care units from 2005 to 2014. Journal of Perinatology 2017;37(3):296-300.
Donovan MD, Griffin BT, Kharoshankaya L, Cryan JF, Boylan GB, Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives. Drugs (2016) 76:647–661.
Yang He, Jun Tang, Meng Zhang, Tao Xiong, Shalini Ojha, Imti Choonara,et al. Efficacy of antiepileptic drugs in neonatal seizures: a systematic review protocol. BMJ Paediatrics Open 2020;4:e000683.
Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, et al. Contemporary profile
of seizures in neonates:a prospective cohort study. J Pediatr 2016;174. 98e103.e1.
Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures—effects on intelligence and on seizure recurrence.N Engl J Med 1990; 322(6):364–369.
Okumura A, The Diagnosis and Treatment of Neonatal Seizures, Chang Gung Med J, 2012;35(5):365-72.
Hallberg B, Blennow M. Investigations for neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):196–201.
Okumura A, Hayakawa F, Kato T, Itomi K, Maruyama K, Kubota T, Suzuki M, Kidokoro H, Watanabe K. Ictal elec-troencephalographic findings of neonatal seizures in preterm infants. Brain Dev 2008;30:261-8.
Stevenson NJ, Vanhatalo S. Designing a trial for neonatal seizure treatment. Seminars in Fetal and Neonatal Medicine 2018;23-217.
Hellstom Westast L, Ingmar Rosen, Continuous brain-function monitoring: state of the art in clinical practice, Semin Fetal Neonatal Med, 2006 Dec;11(6):503-11.
S de Vries L, C Toet M. Amplitude integrated electroencephalography in the full-term newborn, Clin Perinatol, 2006 Sep;33(3):619-32.
Shah DK, Boylan GB, Janet MR. Monitoring of seizures in the newborn, Arch Dis Child Fetal Neonatal Ed, 2012 Jan;97(1):F65-9.
Gossling L, Alix JP, Stavroulakis T, Hart AR,Investigating and managing neonatal seizures in the UK: an explanatory sequentialmixed methods approach, BMC Pediatrics, 2020;20,36.
Kharoshankaya L, Stevenson NJ, Livingstone V, Murray DM, Murphy BP, Ahearne CE, et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy.
Dev Med Child Neurol. 2016;58(12):1242–8.
Kwon JM, Guillet R, Shankaran S, Laptook AR, McDonald SA, Ehrenkranz RA, et al.
Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the neonatal research network hypothermia trial. J Child Neurol. 2011;26(3):322–8.
Oh A, Thurman DJ, Kim H. Independent role of neonatal seizures in subsequent neurological outcomes: a population-based study. Dev Med Child Neurol. 2019;61(6):661–6.
Srinivasakumar P, Zempel J, Trivedi S, Wallendorf M, Rao R, Smith B, et al. Treating EEG seizures in hypoxic ischemic encephalopathy: a randomized controlled trial. Pediatrics. 2015;136(5):e1302–9.
Srinivasakumar P, Zempel J, Trivedi S,Wallendorf M, Rao R, Smith B, et al. Treating EEG seizures in hypoxic ischemic encephalopathy: a randomized controlled trial. Pediatrics 2015;136:e1302e9.
van Rooij LG, Toet MC, van Huffelen AC, Groenendaal F, Laan W, Zecic A, de Haan T, van Straaten IL, Vrancken S, van Wezel G, van der Sluijs J, Ter Horst H, Gavilanes D, LarocheS, Naulaers G, de Vries LS. Effect of treat- ment
of subclinical neonatal seizures detected withaEEG: randomized, controlled trial. Pediatrics 2010;125:e358- 66.
Mohamed El-Dib , Janet S. Soul,The use of phenobarbital and other anti-seizure drugs in newborns. Seminars in Fetal & Neonatal Medicine 2017;22(5):321-327.
Yozawitz E,Stacey A, Pressler RM, Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy, Pediatr Drugs, 2017;19(6):553-567.
Bialer M, White HS. Key factors in the discovery and devel- opment of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9(1):68–82.
Maitre NL, Smolinsky C, Slaughter JC, Stark AR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841–6.
Van Rooij LGM, Hellstron Westas L, Vries L S, Seminars in Fetal and Neonatal Medicine,Treatment of neonatal seizures, 2013;18(4):209-215.
van den Heuvel MP, Kersbergen KJ, de Reus MA, Keunen K, Kahn RS, Groenendaal F, de Vries LS, Benders MJNL. The neonatal connectome during preterm brain development. Cereb Cortex (New York, NY). 2015;25(9):3000–13.
Glykys J, Dzhala VI, Kuchibhotla KV, Feng G, Kuner T, Augustine G, Bacskai BJ, Staley KJ. Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures. Neuron. 2009;63(5):657–72.
Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol 2012;72:363e72.
Frankel S, Medvedeva N, Gutherz S. Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats. Epilepsy Behav 2016;57(Pt A):34e40.
Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999; 38(7): 387–394.
Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to pheno- barbital and intelligence deficits in adult men. JAMA 1995; 274(19): 1518–1525.
Kim J, Kondratyev A, Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther
; 323(1): 165–173.
Kim J-S, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48 (Suppl 5): 19–26.
Brown L, Gutherz S, Kulick C, Soper C, Kondratyev A, Forcelli PA. Profile of retigabineinduced neuronal apoptosis in the developing rat brain. Epilepsia 2016; 57(4): 660–670.
Lekha M. Rao, Shaun A. Hussain , Timothy Zaki , Alexander Cho , Teresa Chanlaw , Meena Garg et al. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic–ischemic encephalopathy. Epilepsy & Behavior 88 (2018) 212–217.
Talos DM, Chang M, Kosaras B, Fitzgerald E, Murphy A, Folk- erth RD, Jensen FE. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res. 2013;73(1):24–30.
Kaushal S, et al. Anticonvulsant drug-induced cell death in the developing white matter of therodent brain. Epilepsia. 2016;57(5):727–34.
Strasser K, et al. Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. Brain Res. 2016;1646:116–24.
Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 2011; 44(4): 265–269.
Khan O, Cipriani C, Wright C, Crisp E, Kirmani B. Role of intravenous levetiracetam for acute seizure management in preterm neonates. Pediatr Neurol 2013; 49(5): 340–343.
İşgüder R, Güzel O, Ağın H, Yılmaz Ü, Akarcan SE, Celik T et al. Efficacy and safety of IV levetiracetam in children with acute repetitive seizures. Pediatr Neurol 2014; 51(5): 688–695.
Tekgül H, Gencpinar P, Çavuşoğlu D, Dündar NO. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population. Seizure 2016; 36: 16–21.
Arzimanoglou A, Lösch C, Garate P, Bentz J. Safety of levetiracetam among infants younger
than 12 months—results from a European multicenter observational study. Eur J Paediatr Neurol 2016; 20(3): 368-375.
Donovan MD, Griffin BT, Kharoshankaya L, Cryan JF, Boylan GB. Pharmaco- therapy for
neonatal seizures: current knowledge and future perspectives. Drugs 2016;76:647e61.
Weeke LC, Schalkwijk S, Toet MC, Van Rooij LGM, De Vries LS, Van Den Broek
MPH. Lidocaine-associated cardiac events in newborns with seizures: incidence, symptoms
and contributing factors. Neonatology 2015;108:130e6.
Daryl C. McHugh, Shannon Lancaster, Louis N. Manganas. A Systematic Review of the
Efficacy of Levetiracetam in Neonatal Seizures. Neuropediatrics, 2018:49(1):12-17.
Ramantani G, Schmitt B, Plecko B, Pressler RM, Wohlrab G, Klebermass-Schrehof K, et al. Neonatal Seizures—Are We there Yet?, Neuropediatrics, 2019:50(5):280-293.
Slaughter LA, Patel AD, Slaughter JL. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol 2013;28(03):351–364.
Shellhaas RA, Chang T, Wusthoff CJ, et al; Neonatal Seizure Registry Study Group.Treatment duration after acute symptomaticseizures in neonates: a multicenter cohort study.J Pediatr 2017;181:298–301.e1.
Gregory L Holmes, Seizure-induced neuronal injury: animal data, Neurology, 2002 Nov 12;59(9 Suppl 5):S3-6.
Freeman JM, Beware: The misuse of technology and the law of unintended consequences, Neurotherapeutics 2007, 4; 549–554.
- Abstract Viewed: 226 times